Brain-computer interface (BCI) continues to receive positive developments! In the afternoon, news suddenly emerged that BCI company BrainCo has reportedly submitted a confidential application for an IPO in Hong Kong. Previously, the National Medical Products Administration released a public notice on the initiation of two recommended medical device industry standards, including the "Reliability Verification Method for Invasive Equipment of Medical Devices Using Brain-Computer Interface Technology." Human brain engineering concept stocks were repeatedly active in the afternoon, with Dowstone Technology and Yanshan Technology hitting the daily limit-up. The strategic investor of BrainCo, Lens Technology (market cap already exceeding 200 billion yuan), which exclusively undertakes the mass production of BrainCo's core hardware modules, surged over 10% today.
Positive developments continue to ferment. Recently, favorable news involving human brain engineering has been continuously fermenting. On January 5th, Elon Musk announced Neuralink's highly ambitious 2026 plan on a social media platform, with the core signal being "transitioning from the laboratory to mass production." On January 9th, the National Medical Products Administration publicized plans for formulating two recommended medical device industry standards: "Reliability Verification Method for Invasive Equipment of Medical Devices Using Brain-Computer Interface Technology" and "Paradigm Design and Application Specifications for Motor Function Reconstruction of Medical Devices Using Brain-Computer Interface Technology." In the afternoon, two more heavyweight pieces of news arrived. Media reported that BrainCo has reportedly submitted a confidential application for a Hong Kong IPO. Southwest Securities stated that BrainCo has previously completed financing of approximately 2 billion yuan, with investors including industrial capital from IDG, Walden International, Lens Technology, Lingyi iTech, and Will Semiconductor, making it second only to Neuralink in scale, highlighting the capital recognition and industrial synergy expectations for the leading non-invasive brain-computer interface commercialization company. Lens Technology stated on its investor interaction platform that the company is a strategic investor in BrainCo and exclusively undertakes the mass production of BrainCo's core hardware modules. In November 2025, Lens Technology and BrainCo jointly donated a large batch of intelligent bionic limbs to the Hunan Provincial Disabled Persons' Federation, with the core modules all coming from Lens Technology's production lines. Simultaneously, the company has had over 10 years of deep cooperation with a major North American customer and is its Tier-1 core supplier. Leveraging the mass production experience accumulated from projects like BrainCo and its strong precision manufacturing capabilities, the company is actively seeking cooperation. Another piece of news pointed out that recently, a signed article by Ming Dong, Director of the Haihe Laboratory of Brain-Computer Interaction and Human-Machine Integration and Vice President of Tianjin University, mentioned that the team from the Tianjin University Haihe Laboratory of Brain-Computer Interaction and Human-Machine Integration focuses on the field of non-invasive brain-computer interfaces. Currently, they have formed a full-chain layout integrating high-performance devices, chips, algorithms, platforms, system integration, key foundational technologies, and application sets.
It is worth noting that the JPM Conference is approaching, drawing attention to the latest developments in the global biomedical industry. The 44th J.P. Morgan Healthcare Conference will kick off in San Francisco on January 12th. It is the world's largest and most information-intensive healthcare investment and partnership event, focusing on the latest trends and new expectations in the global biomedical industry.
Is the industry entering an acceleration phase? China's top-level planning and layout in the field of brain-computer interfaces continue to strengthen. On August 7, 2025, seven departments, including the Ministry of Industry and Information Technology, jointly issued the "Brain-Computer Interface Industry Innovation Development Action Plan (2025-2028)," highlighting national support for the development of the BCI industry; the suggestions for the "15th Five-Year Plan" listed "brain-computer interface" as one of the six future industries requiring forward-looking layout, indicating continuous policy support. Huafu Securities believes that both the global and Chinese markets are showing rapid growth trends, with the global market expected to reach $12.4 billion by 2034 and the Chinese market expected to reach 6.14 billion yuan by 2028. The industry is accelerating its transition from research and development to commercialization. Southwest Securities believes that looking at BCI sub-sectors: 1. Invasive BCI in China has just begun clinical trials; focus on leading invasive companies, as well as those in flexible electrodes, implantation technology, and specific scenario algorithms that are expected to become key drivers for the industry; 2. For semi-invasive/interventional paths, focus on "data readout" and "cohort size," both of which can significantly enhance commercialization certainty and industry attention; 3. For non-invasive BCI, focus on the rare combination driven by both "medical + consumer" wheels, as this overall technical path is seeing faster commercialization landing.
It is worth noting that OpenAI is also betting on AI healthcare. On January 8th, OpenAI announced the launch of ChatGPT Health, which integrates multi-source health data by connecting electronic medical records, health applications, and disease health consultations, and generates personalized health recommendations. This move marks the official acceleration of general large model penetration into healthcare scenarios. Domestic AI healthcare applications are also showing an accelerated development trend. Ant Group's AI healthcare product, Afu, has surpassed 15 million monthly active users. Major internet companies like ByteDance, Baidu, JD.com, and Tencent have successively made layouts. The deep integration of internet healthcare and AI is gradually becoming an important direction in the AI era.
Comments